u 69593 has been researched along with lorglumide in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Anzini, M; Cappelli, A; Clarke, GD; De Benedetti, PG; Mennuni, L; Menziani, MC; Sbacchi, M; Vomero, S | 1 |
1 other study(ies) available for u 69593 and lorglumide
Article | Year |
---|---|
Synthesis, biological evaluation, and quantitative receptor docking simulations of 2-[(acylamino)ethyl]-1,4-benzodiazepines as novel tifluadom-like ligands with high affinity and selectivity for kappa-opioid receptors.
Topics: Amino Acid Sequence; Analgesics; Animals; Benzodiazepines; Binding, Competitive; Brain; Cerebral Cortex; Computer Graphics; Conserved Sequence; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Enkephalin, Leucine-2-Alanine; Enkephalins; Guinea Pigs; Humans; Ligands; Mice; Models, Molecular; Molecular Sequence Data; Molecular Structure; Pancreas; Protein Conformation; Radioligand Assay; Rats; Receptors, Cholecystokinin; Receptors, Opioid, kappa; Sequence Homology, Amino Acid; Sincalide; Structure-Activity Relationship | 1996 |